ИККИНЧИ ТУР ҚАНДЛИ ДИАБЕТ ВА ЮРАК ИШЕМИК КАСАЛЛИГИ МАВЖУД БЎЛГАН БЕМОРЛАРДА КОРОНАР СТЕНТЛАШ АМАЛИЁТИДАН СЎНГ ОЛИБ БОРИЛГАН АНТИТРОМБОТИК ТЕРАПИЯНИНГ КЛИНИК НАТИЖАЛАРИ.
Abstract
Юрак-қон томир касалликлари инсоният соғлиғи учун энг катта хавф омили ҳисобланади ва дунё бўйлаб ўлим сабаблари ичида биринчи ўринни эгаллайди [1,2]. Улар орасида юрак ишемик касаллиги (ЮИК) айниқса кенг тарқалган бўлиб, 2-тур қандли диабет (ҚД2) билан асоратланган ҳолатларда клиник кечиши оғирлашади ва асоратлар хавфи ортади [3,4].
References
American Diabetes Association. (2023). Standards of Medical Care in Diabetes—2023. Diabetes Care, 46(Suppl. 1), S1–S154.
A.T. Akhmedov (2024). Impact of cytokines on the onset and progression of arterial hypertension. Eurasian Journal of Medical and Natural Sciences, 4 (6), 116-123. doi: 10.5281/zenodo.12154505.
Akhmedov, A. T., & Sharipov, Z. R. (2023). The role of cytokines in the development of arterial hypertension. Int J Med Sci Clin Res, 3(03), 59-67.
Matsushita, K., & Coresh, J. (2020). Diabetes, CKD, and cardiovascular disease. Journal of the American Society of Nephrology, 31(2), 236–245.
Ridker, P. M., Everett, B. M., Thuren, T., et al. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease. New England Journal of Medicine, 377(12), 1119–1131..
Roth, G. A., Mensah, G. A., Johnson, C. O., et al. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019. Journal of the American College of Cardiology, 76(25), 2982–3021.
Schramm, T. K., Gislason, G. H., Køber, L., et al. (2019). Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk. Circulation, 117(15), 1945–1954.
Seferović, P. M., Petrie, M. C., Filippatos, G. S., et al. (2018). Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association. European Journal of Heart Failure, 20(5), 853–872.
Wiviott, S. D., Braunwald, E., McCabe, C. H., et al. (2007). Prasugrel versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 357(20), 2001–2015.
World Health Organization. (2023). Cardiovascular diseases (CVDs). Retrieved from https://www.who.int.
